Evidence map›Paper›PMID 34282119›Full record

ArticleTranslational psychiatry2021

Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes.

Daiki Sasabayashi, Yoichiro Takayanagi, Tsutomu Takahashi, Shimako Nishiyama, Yuko Mizukami, Naoyuki Katagiri, Naohisa Tsujino, Takahiro Nemoto, Atsushi Sakuma, Masahiro Katsura and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 1 country.

Daiki SasabayashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan. ds179@med.u-toyama.ac.jp.ORCID http://orcid.org/0000-0001-8512-7438
Yoichiro TakayanagiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.ORCID http://orcid.org/0000-0001-7872-8307
Tsutomu TakahashiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.ORCID http://orcid.org/0000-0003-3213-6183
Shimako NishiyamaDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Yuko MizukamiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Naoyuki KatagiriDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.
Naohisa TsujinoDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.
Takahiro NemotoDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.
Atsushi SakumaDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Masahiro KatsuraDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Noriyuki OhmuroOsaki Citizen Hospital, Miyagi, Japan.
Naohiro OkadaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mariko TadaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7630-8779
Motomu SugaDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Norihide MaikusaCenter for Evolutionary Cognitive Sciences (ECS), Graduate School of Art and Sciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0943-4684
Shinsuke KoikeDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3375-236X
Atsushi FuruichiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Mikio KidoDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Kyo NoguchiDepartment of Radiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Hidenori YamasueDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2748-6317
Kazunori MatsumotoKokoro no Clinic OASIS, Sendai, Japan.
Masafumi MizunoDepartment of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.
Kiyoto KasaiDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4443-4535
Michio SuzukiDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
University of Toyama · JPThe University of Tokyo · JPToho University · JPTohoku University Hospital · JPAkebono Clinic · JPHamamatsu University School of Medicine · JPOsaki Citizen Hospital · JPTeikyo Heisei University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP16dk0307029h0003Japan Agency for Medical Research and Development (AMED) JP20dm0207069Japan Agency for Medical Research and Development (AMED) JP20dm0307001Japan Agency for Medical Research and Development (AMED) JP20dm0307004MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06280MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06395MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06399MEXT | Japan Society for the Promotion of Science (JSPS) JP16K21720MEXT | Japan Society for the Promotion of Science (JSPS) JP18K07549MEXT | Japan Society for the Promotion of Science (JSPS) JP18K07550MEXT | Japan Society for the Promotion of Science (JSPS) JP18K15509MEXT | Japan Society for the Promotion of Science (JSPS) JP19H03579MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03596MEXT | Japan Society for the Promotion of Science (JSPS) JP20H03598MEXT | Japan Society for the Promotion of Science (JSPS) JP20KK0193MEXT | Japan Society for the Promotion of Science (JSPS) JP24390281MEXT | Japan Society for the Promotion of Science (JSPS) JP26461738
6 · The paper itself

Abstract

Although widespread cortical thinning centered on the fronto-temporal regions in schizophrenia has been reported, the findings in at-risk mental state (ARMS) patients have been inconsistent. In addition, it remains unclear whether abnormalities of cortical thickness (CT) in ARMS individuals, if present, are related to their functional decline irrespective of future psychosis onset. In this multicenter study in Japan, T1-weighted magnetic resonance imaging was performed at baseline in 107 individuals with ARMS, who were subdivided into resilient (77, good functional outcome) and non-resilient (13, poor functional outcome) groups based on the change in Global Assessment of Functioning scores during 1-year follow-up, and 104 age- and sex-matched healthy controls recruited at four scanning sites. We measured the CT of the entire cortex and performed group comparisons using FreeSurfer software. The relationship between the CT and cognitive functioning was examined in an ARMS subsample (n = 70). ARMS individuals as a whole relative to healthy controls exhibited a significantly reduced CT, predominantly in the fronto-temporal regions, which was partly associated with cognitive impairments, and an increased CT in the left parietal and right occipital regions. Compared with resilient ARMS individuals, non-resilient ARMS individuals exhibited a significantly reduced CT of the right paracentral lobule. These findings suggest that ARMS individuals partly share CT abnormalities with patients with overt schizophrenia, potentially representing general vulnerability to psychopathology, and also support the role of cortical thinning in the paracentral lobule as a predictive biomarker for short-term functional decline in the ARMS population.

Indexed as

Psychotic DisordersSchizophreniaCerebral CortexHumansJapanMagnetic Resonance Imaging

Identifiers

PMID34282119
PMCPMC8289863
OpenAlexW3186249161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.